Astellas Pharma Inc. (ALPMF)
OTCMKTS · Delayed Price · Currency is USD
11.00
0.00 (0.00%)
Sep 17, 2025, 8:00 PM EDT
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of $20.06 billion as of September 19, 2025. Its market cap has decreased by -9.88% in one year.
Market Cap
20.06B
Enterprise Value
24.62B
Revenue
13.48B
Ranking
n/a
PE Ratio
35.49
Stock Price
$11.00
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 20.06B, an increase of 188.16%. That is a compound annual growth rate of 3.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 20.06B | 14.79% |
| Dec 30, 2024 | 17.48B | -18.50% |
| Dec 29, 2023 | 21.44B | -22.67% |
| Dec 30, 2022 | 27.73B | -7.87% |
| Dec 30, 2021 | 30.10B | 5.02% |
| Dec 30, 2020 | 28.66B | -10.92% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 697.08M |
| Tian'an Technology Group | 609.94M |
| Glass House Brands | 567.62M |
| Northwest Biotherapeutics | 378.51M |
| CytoDyn | 352.05M |
| American Oncology Network | 345.48M |